Different species can have various maximum lifespans, some with exceptional longevity, yet the underlying cellular and molecular mechanisms remain poorly understood. Despite rapid advances in single-cell transcriptomics, resources that systematically connect single-cell gene…
Abstract
Different species can have various maximum lifespans, some with exceptional longevity, yet the underlying cellular and molecular mechanisms remain poorly understood. Despite rapid advances in single-cell transcriptomics, resources that systematically connect single-cell gene expression profiles to species lifespan are limited. We hereby present the Longevity & Aging Cell Atlas (LACA), a database that integrates single-cell transcriptomic datasets across 134 species with their maximum lifespans. LACA includes over 148 million cells with 190 annotated cell types from single-cell datasets. LACA also has a cross-species analytical toolbox of longevity gene comparison, gene-lifespan correlation, and cell-lifespan correlation. These tools allow researchers to better interpret both evolutionarily conserved longevity mechanisms and the evolution of species-specific adaptations in longevity mechanisms without extensive computational expertise. LACA also provides a centenarian single-cell atlas and a human immune aging multi-omics atlas, demonstrating the analytical capability of the resource, as well as 11 different modules for longevity-related analysis, an integrated knowledge graph including curated longevity knowledge bases, and a retrieval-augmented research agent to further facilitate functional interpretation. The database is freely available at https://www.longevityaging.net/ or http://8.142.154.29/LACA/.
AI-generated longevity analysis. Check claims against the paper.
Summary
LACA integrates single-cell transcriptomic data from 134 species to identify conserved and species-specific molecular programs associated with maximum lifespan. This resource is relevant because it provides a systematic, cross-species framework for discovering the cellular and molecular mechanisms underlying exceptional longevity, moving beyond symptom treatment to address the root causes of aging through comparative genomics.
Nutrient availability is typically treated as an input to the target of rapamycin (TOR) pathway, the conserved controller of growth, metabolism and ageing. Yet, membrane transporters are not merely suppliers of the amino acids and other nutrients that activate TOR, they are…
Abstract
Nutrient availability is typically treated as an input to the target of rapamycin (TOR) pathway, the conserved controller of growth, metabolism and ageing. Yet, membrane transporters are not merely suppliers of the amino acids and other nutrients that activate TOR, they are integral components of the signalling network itself, and TOR in turn governs their activity, abundance, trafficking and degradation. This bidirectional coupling - including transporters that double as receptors, or 'transceptors' - is mechanistically defined in budding yeast, where the TORC1 complex acts through the Npr1-arrestin axis and vacuolar Gtr/EGO amino acid sensing, conserved in fission yeast, where TOR links nitrogen transport and vacuolar function to growth, stress and lifespan; and elaborated in metazoans across intestinal and fat-body uptake, endocrine relays and lysosomal gatekeepers such as SLC38A9, NPC1 and TRPML1. We propose that TOR-transporter coupling offers a conserved and mechanistically compelling, but still, largely untested, route linking nutrient transport to stress resistance and lifespan across eukaryotes and we advance it as a framework to guide future causal work rather than a settled conclusion.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper proposes that the bidirectional coupling between the TOR pathway and membrane transporters is a conserved, mechanistically defined route linking nutrient transport to stress resistance and lifespan across eukaryotes. This is relevant because it identifies a fundamental conserved mechanism (TOR signaling) central to aging biology, but the impact is limited as the authors explicitly frame this as a conceptual review and framework for future work rather than presenting new causal experimental data or a novel intervention.
Mitochondrial failure is a convergent driver of neuronal aging and neurodegeneration, yet upstream factors that link age-associated changes to mitochondrial homeostasis remain incompletely defined. Melatonin, which is synthesized within neuronal mitochondria, declines with age…
Abstract
Mitochondrial failure is a convergent driver of neuronal aging and neurodegeneration, yet upstream factors that link age-associated changes to mitochondrial homeostasis remain incompletely defined. Melatonin, which is synthesized within neuronal mitochondria, declines with age and is further exacerbated in several neurodegenerative disorders. Here we show that endogenous melatonin is required to maintain cerebral mitochondrial biogenesis and mitochondrial quality through the SIRT1/PGC-1α signaling axis. Across young (8-week), adult (20-week), and middle-aged (1-year) mouse brains, aging was associated with reduced SIRT1/PGC-1α, decreased mtDNA copy number, and diminished abundance of oxidative phosphorylation proteins. Human hippocampal samples from older donors similarly exhibited reduced SIRT1/PGC-1α but retained mitochondrial protein abundance while accumulating oxidatively damaged mitochondria and showing reduced LC3B, consistent with impaired mitochondrial quality control. In aralkylamine N-acetyltransferase knockout (AANAT-KO) mice, endogenous melatonin deficiency suppressed SIRT1/PGC-1α, NRF1, and TFAM in an age-dependent manner, reduced mtDNA and mitochondrial transcript abundance, lowered mitochondrial protein levels, and increased mitochondrial oxidative damage. Melatonin supplementation restored the biogenesis program, increased mtDNA and mitochondrial transcripts, and rescued respiratory chain protein abundance. Finally, mitochondrial transplantation experiments indicated that mitochondrial quality contributes to neuronal integrity. Melatonin-deficient mitochondria induced neurite degeneration in wild-type neurons, whereas wild-type mitochondria rescued neurite architecture and improved survival in melatonin-deficient neurons. Together, these findings identify endogenous melatonin as a regulator of cerebral mitochondrial biogenesis and suggest that melatonin decline contributes to mitochondrial-mediated neuritic degeneration and neuronal loss.
AI-generated longevity analysis. Check claims against the paper.
Summary
Endogenous melatonin is required to maintain cerebral mitochondrial biogenesis via the SIRT1/PGC-1α axis, and its age-related decline drives mitochondrial dysfunction and neuronal degeneration. This paper is relevant because it identifies a specific, endogenous molecular mechanism (melatonin signaling) that links aging to a root cause of neurodegeneration (mitochondrial failure), suggesting that restoring this pathway could mitigate age-related neuronal loss rather than just treating symptoms.
Mammalian cells undergo irreversible proliferation arrest when exposed to stresses, a phenomenon termed cellular senescence. Various types of stress induce cellular senescence; nonetheless, senescent cells show similar phenotypes overall. Cells undergo cellular senescence…
Abstract
Mammalian cells undergo irreversible proliferation arrest when exposed to stresses, a phenomenon termed cellular senescence. Various types of stress induce cellular senescence; nonetheless, senescent cells show similar phenotypes overall. Cells undergo cellular senescence through similar mechanisms, regardless of the type of stress encountered. Here, we aimed to reveal the mechanisms underlying cellular senescence. We have previously shown that lamin B receptor (LBR), which is a protein that regulates heterochromatin organization, was downregulated in senescent cells, and downregulation of LBR induced cellular senescence. Additionally, we have shown that downregulation of protein synthesis effectively suppressed cellular senescence. Accordingly, chromatin organization and protein synthesis are implicated in the regulation of this process. We examined their roles and revealed that protein synthesis was upregulated during the induction of cellular senescence, and upregulated protein synthesis caused disturbed proteostasis that led to the decreased LBR protein levels. Furthermore, we showed that decreased LBR protein levels induced cellular senescence through altered chromatin organization and increased genome instability. Importantly, these findings revealed a link between protein synthesis and chromatin organization, and accounted for the phenotypes of senescent cells showing disturbed proteostasis, altered chromatin organization and increased genome instability. Our findings provide novel insights into the mechanisms of cellular senescence.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper claims that disturbed proteostasis, triggered by upregulated protein synthesis, leads to decreased Lamin B receptor levels, which in turn alters chromatin organization and induces cellular senescence. This is relevant to longevity research because it identifies a specific mechanistic pathway linking protein homeostasis to the senescence phenotype, a key driver of aging, offering potential targets for interventions aimed at delaying or reversing cellular aging.
Regeneration restores tissues lost to injury, but its consequences may extend beyond local repair. Whether regeneration produces lasting systemic effects on developmental timing and lifespan remains poorly understood. Here we investigated the long-term consequences of repeated…
Abstract
Regeneration restores tissues lost to injury, but its consequences may extend beyond local repair. Whether regeneration produces lasting systemic effects on developmental timing and lifespan remains poorly understood. Here we investigated the long-term consequences of repeated regeneration in the marine annelid Platynereis dumerilii. To determine these consequences, we repeatedly amputated juveniles at monthly intervals, removing approximately half of the body after each regenerative cycle, and compared them with control unamputated siblings. Repeatedly regenerating worms lived approximately 1.5-fold longer than controls and showed delayed sexual maturation, including delayed gametogenic progression at the morphological and transcriptional levels. Somatic progression was also delayed, as indicated by slower accumulation of pigmentation associated with developmental progression, while regenerative competence was maintained across amputations. To investigate whether regeneration engages distant tissues, we compared head transcriptomes from amputated and unamputated worms. Posterior amputation altered head gene expression within 2 hours, including increased expression of genes associated with younger head profiles, such as igf-like and alpha-tubulin. Together, our results show that repeated regeneration not only restores lost tissues but prolongs the juvenile state, delays reproductive and somatic maturation, and extends lifespan, a phenomenon we term the Highlander effect. These findings suggest that regeneration may influence organismal life history beyond tissue replacement, with neurohormonal signaling as a potential mediator.
AI-generated longevity analysis. Check claims against the paper.
Summary
Repeated regeneration in Platynereis dumerilii prolongs the juvenile stage and extends lifespan by delaying sexual and somatic maturation. This is relevant because it identifies a specific physiological mechanism (the "Highlander effect") where tissue regeneration actively alters developmental timing and extends lifespan, providing a model to study the systemic signaling pathways that link regeneration to aging and life history.
The evolutionarily conserved insulin/IGF-1 signalling pathway (IIS) shapes life-history traits largely through downstream transcription factors including SKN-1. Reduced IIS (rIIS) in adulthood robustly extends Caenorhabditis elegans lifespan, yet developmental rIIS has long been…
Abstract
The evolutionarily conserved insulin/IGF-1 signalling pathway (IIS) shapes life-history traits largely through downstream transcription factors including SKN-1. Reduced IIS (rIIS) in adulthood robustly extends Caenorhabditis elegans lifespan, yet developmental rIIS has long been considered unable to extend lifespan and costly to fitness, a conclusion drawn almost entirely from experiments at 25{degrees}C, near the species' upper thermal limit. Here we knocked down daf-2 during development in wild-type and skn-1 loss-of-function nematodes across constant and fluctuating temperatures. Contrary to the prevailing view, developmental daf-2 knockdown extended lifespan at constant 15{degrees}C in both backgrounds, but not at 25{degrees}C, revealing that its late-life benefit is strongly temperature-dependent and, under constant conditions, independent of skn-1. Under daily 15-25{degrees}C cycling, developmental daf-2 knockdown again extended lifespan, but whether this required skn-1 was itself determined by the temperature experienced at the start of development. Lifespan extension was accompanied by condition-specific reproductive costs. Together, our results identify a developmental window in which IIS, skn-1 and temperature interact to set adult ageing trajectories and show that the thermal environment determines whether reducing IIS during development extends lifespan.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper demonstrates that developmental knockdown of the insulin/IGF-1 receptor (daf-2) extends C. elegans lifespan at lower temperatures (15°C) but not at higher temperatures (25°C), and that this effect is mediated by SKN-1 in a temperature-dependent manner. This is relevant because it challenges the long-held dogma that developmental reduction of IIS is always costly and does not extend lifespan, revealing that the thermal environment is a critical determinant of whether this conserved longevity pathway functions to extend life during development, which has implications for understanding the context-dependency of aging interventions.
The mutation accumulation theory attributes aging to the decline in selection strength with age. While classical models assume fixed ages of mutation expression, empirical evidence reveals significant interindividual variation in the timing of mutation expression. Here, we…
Abstract
The mutation accumulation theory attributes aging to the decline in selection strength with age. While classical models assume fixed ages of mutation expression, empirical evidence reveals significant interindividual variation in the timing of mutation expression. Here, we develop mathematical models incorporating this stochasticity. By tracking the fate of lethal mutations, we characterize the boundary of the "selection shadow" where genetic drift overcomes purging selection against such mutations-a fundamental evolutionary limit, termed the lifespan drift barrier, setting a theoretical benchmark for the pace of aging. Our results show that for both stochastic age- and state-dependent mutations, variation in the age of mutation expression generally pushes back this lifespan drift barrier. This outcome is a universal consequence of the inherent convexity of the selection gradient under extrinsic mortality: early expression in a subset of individuals intensifies purging selection, thereby raising the drift barrier. In addition, we demonstrate that while this variance shifts this evolutionary threshold (determining the pace of aging), it leaves the mortality trajectory at mutation-selection balance (the shape of aging) fundamentally unaltered. These findings thus help explain how the pace and shape of aging can become uncoupled.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper claims that stochastic variation in the timing of mutation expression pushes back the evolutionary limit of lifespan (the drift barrier) without altering the shape of the mortality trajectory. This is relevant because it provides a theoretical framework explaining how the pace of aging can be extended beyond classical mutation accumulation predictions, offering insights into the fundamental evolutionary constraints on longevity.
Changes in the metabolic network that sustain NAD+ during aging remain poorly understood. Analysis of steady state levels is insufficient to reveal whether biosynthetic or consumption pathways are perturbed or preserved. Here, we address this gap in understanding by integrating…
Abstract
Changes in the metabolic network that sustain NAD+ during aging remain poorly understood. Analysis of steady state levels is insufficient to reveal whether biosynthetic or consumption pathways are perturbed or preserved. Here, we address this gap in understanding by integrating metabolomics, proteomics, gene-expression profiling, and stable-isotope tracing across the Caenorhabditis elegans adult lifespan. NAD abundance increases with age despite reductions in selected biosynthetic components. Tracing reveals reduced mid-adult incorporation of nicotinamide and nicotinic acid into NAD, alongside declining nicotinamide riboside abundance and loss of detectable nicotinic acid-derived labeling into this precursor. Early mitochondrial Complex I remodeling accompanies sustained changes in redox and energetic indices. Disruption of NAD-consuming or salvage enzymes reduces reproduction and lifespan, whereas precursor supplementation provides no longevity benefit under the conditions tested. Together, these findings reveal that NAD accumulation can coexist with extensive metabolic remodeling, establishing the importance of evaluating network dynamics beyond cofactor abundance.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper demonstrates that NAD+ accumulation in aging C. elegans coexists with extensive metabolic remodeling and that precursor supplementation does not extend lifespan under the tested conditions. This is relevant because it challenges the prevailing "NAD+ decline" hypothesis by showing that cofactor abundance is not the sole determinant of aging, thereby refining the mechanistic understanding of metabolic networks in longevity.
Telomere shortening is a hallmark of aging, yet telomere length (TL) varies considerably between individuals and is strongly influenced by inheritance. In mice, efficient mitochondrial function and low reactive oxygen species (ROS) production are essential for telomere…
Abstract
Telomere shortening is a hallmark of aging, yet telomere length (TL) varies considerably between individuals and is strongly influenced by inheritance. In mice, efficient mitochondrial function and low reactive oxygen species (ROS) production are essential for telomere elongation during early embryogenesis. As mitochondrial DNA (mtDNA) encodes several subunits of the electron transport chain, we investigated whether mtDNA variants influence TL using a transmitochondrial cybrid model. Platelet-derived mitochondria from human donors with varying TL were introduced into mtDNA-depleted cells. Donor blood TL inversely correlated with cybrid ROS levels, suggesting that specific mtDNA variants may support telomere maintenance by enhancing mitochondrial fitness. During cybrid formation, a transient oxidative stress phase precedes cellular adaptation. At this stage, mtDNA variants associated with reduced complex I (CI) activity triggered rapid telomere shortening, which was rescued by antioxidant and NAD
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper claims that specific human mitochondrial DNA variants influence telomere length by modulating mitochondrial fitness and reactive oxygen species levels. This is relevant to longevity research because it identifies a potential mechanistic link between mitochondrial genetic variation and a core hallmark of aging (telomere shortening), offering insights into the genetic determinants of cellular aging rates.
Frailty summarizes aging-related decline independently of chronological age. Although the gut microbiome covaries with frailty in older populations, its causal contribution to frailty remains unclear. We profiled middle-aged (72-week-old) and young (10-week-old) male mice across…
Abstract
Frailty summarizes aging-related decline independently of chronological age. Although the gut microbiome covaries with frailty in older populations, its causal contribution to frailty remains unclear. We profiled middle-aged (72-week-old) and young (10-week-old) male mice across six data layers including physio-behavioral phenotypes, fecal metagenomic taxa and pathways, serum lipidome, and liver and hippocampal transcriptomes. Aged mice exhibited elevated frailty, reduced motor coordination, and microbiome alterations, with members of
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper claims that depleting the gut microbiome in late-life attenuates aging-induced frailty in male mice. This is relevant because it investigates a causal mechanism linking the microbiome to the physiological decline of aging, rather than just treating a specific age-related disease symptom.
Autophagy is an essential catabolic pathway that safeguards cellular and tissue homeostasis, yet the systemic consequences of its impairment in mammals remain poorly defined because complete autophagy ablation is embryonic or perinatal lethal. Here, we generate ATG4A-only mice…
Abstract
Autophagy is an essential catabolic pathway that safeguards cellular and tissue homeostasis, yet the systemic consequences of its impairment in mammals remain poorly defined because complete autophagy ablation is embryonic or perinatal lethal. Here, we generate ATG4A-only mice, a model in which ATG4A is the sole remaining ATG4 protease due to combined ATG4B/C/D deletion. Through comprehensive biochemical and cellular analyses, we delineate the in vivo substrate specificity of ATG4A and demonstrate that it sustains only minimal ATG8 priming, uncovering a previously unrecognized functional asymmetry within the mammalian ATG4-ATG8 system. ATG4A-only mice exhibit a profound but incomplete whole-body autophagy deficiency that disrupts multiple organ systems and triggers a premature aging syndrome marked by increased DNA damage, systemic senescence, metabolic dysfunction, and dramatically shortened lifespan. Integrating these findings with comparisons to additional ATG4-deficient models, we show that organismal longevity scales with residual autophagic competence. Together, our work reveals how graded reductions in autophagy integrity influence tissue fitness and aging, establishing autophagic capacity as a key determinant of mammalian lifespan.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper demonstrates that organismal longevity in mammals scales directly with residual autophagic competence, establishing autophagy capacity as a fundamental determinant of lifespan. This is highly relevant because it provides a genetic model for a premature aging syndrome caused by systemic autophagy impairment, offering critical insights into the root cause of aging and validating autophagy as a key target for lifespan extension interventions.
Elevated circulating very-long-chain ceramides are associated with increased cardiovascular disease risk, yet the underlying mechanisms remain unclear. Here, we identify ceramide synthase 2 (CerS2)-derived Cer 24:0 as a critical mediator of endothelial senescence-a key driver of…
Abstract
Elevated circulating very-long-chain ceramides are associated with increased cardiovascular disease risk, yet the underlying mechanisms remain unclear. Here, we identify ceramide synthase 2 (CerS2)-derived Cer 24:0 as a critical mediator of endothelial senescence-a key driver of cardiovascular disease progression. CerS2 was upregulated in senescent HUVECs and in aortas from aged mice, coinciding with marked Cer 24:0 elevation. Isotopic labeling confirmed that excess Cer 24:0 accumulates in mitochondria, triggering structural damage and mtDNA release into the cytosol, thereby activating the cGAS-STING pathway, driving a pro-inflammatory cascade and sub-lethal stress that are tightly linked to cellular senescence. Accordingly, reducing Cer 24:0 content in senescent HUVECs by CerS2 knockdown restored mitochondrial function and reversed senescence phenotypes. Our findings demonstrate that CerS2-driven Cer 24:0 accumulation within mitochondria of senescent endothelial cells disrupts mitochondrial integrity and endothelial homeostasis, identifying CerS2 as a potential target to mitigate endothelial senescence.
AI-generated longevity analysis. Check claims against the paper.
Summary
CerS2-derived Cer 24:0 accumulation in mitochondria triggers cGAS-STING activation, driving endothelial senescence, and its reduction reverses these phenotypes. This paper is relevant because it identifies a specific molecular mechanism linking lipid metabolism to cellular senescence, a core hallmark of aging, and demonstrates that targeting this pathway can reverse senescence-associated damage, offering a potential intervention for age-related vascular dysfunction.
Subtle senescence-associated transcriptional changes in pluripotent stem cells are not fully captured by conventional pluripotency or senescence markers, yet may constrain lineage potential. Given that human endogenous retrovirus (HERV) derepression reflects chromatin relaxation…
Abstract
Subtle senescence-associated transcriptional changes in pluripotent stem cells are not fully captured by conventional pluripotency or senescence markers, yet may constrain lineage potential. Given that human endogenous retrovirus (HERV) derepression reflects chromatin relaxation during aging, HERV signatures may serve as sensitive proxies for latent age-associated states. Using a parallel system of young and replicatively senescent hESC-derived mesenchymal progenitor cells and their reprogrammed iPSCs, candidate senescence-associated HERVs (cSA-HERVs) were identified, from which validated (vSA-HERV) and robust (rSA-HERV) subsets were defined exclusively within this model. rSA-HERV expression remained elevated in O-IPS (iPSCs reprogrammed from senescent MPCs) despite pluripotent reprogramming, and this residue correlated with accelerated senescence upon redifferentiation. Cross-stage comparison further revealed that the parental H9 hESC line, despite its designation as a "young" pluripotent control, exhibited elevated rSA-HERV signal relative to early-passage expectations, suggesting latent transcriptional liabilities may accumulate even in ostensibly young cells. Applied to public iPSC datasets, the rSA-HERV panel detected lines with normal pluripotency markers that nevertheless carried elevated age-associated HERV signals. These findings raise the possibility that certain SA-HERV elements, such as rSA-HERV defined in this model, may serve as cross-lineage markers of intrinsic aging trends across pluripotent and somatic cellular systems.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper claims that specific human endogenous retrovirus (HERV) signatures persist in induced pluripotent stem cells (iPSCs) reprogrammed from senescent cells and correlate with accelerated aging upon redifferentiation. This is relevant to longevity research as it identifies a potential molecular "memory" of aging that survives reprogramming, offering a sensitive biomarker for intrinsic cellular age that could inform strategies for rejuvenation or the assessment of cellular health in regenerative medicine.
Across dog breeds, the inverse correlation between body size and lifespan is well documented, but its genetic basis remains poorly understood, in part because size and lifespan are confounded at the breed level. Here, we assembled the Cani-DNA discovery cohort of 540 dogs from…
Abstract
Across dog breeds, the inverse correlation between body size and lifespan is well documented, but its genetic basis remains poorly understood, in part because size and lifespan are confounded at the breed level. Here, we assembled the Cani-DNA discovery cohort of 540 dogs from 27 breeds, with 20 dogs per breed, genotyped by low-pass whole-genome sequencing and imputation. We performed genome-wide association studies (GWAS) of breed-average body weight, breed-median lifespan and individual age at death, and tested the age-at-death loci for replication in the GRLS replication cohort of 3,024 Golden Retrievers. The GWAS of breed-average body weight recovered established body-size loci, confirming that the cohort could detect known associations. Of the 69 breed-weight loci, 30 were shared with breed-median lifespan, and at all of them the allele increasing body weight was associated with shorter lifespan. At the individual level, age at death, with breed-average body weight as a covariate, identified loci distinct from all breed-level loci. Three of them, the CDH4, TSHZ3 and TSC22D2 loci, replicated in the GRLS replication cohort. In humans, CDH4 and TSHZ3 have been implicated in longevity, and the region orthologous to the TSC22D2 locus has been associated with markers of biological ageing. Together, these results identify genetic variation associated with the lifespan of individual dogs beyond breed body size, and support the dog as a model in which genetic leads on ageing can be identified.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper identifies specific genetic loci (CDH4, TSHZ3, TSC22D2) associated with individual canine lifespan independent of breed body size, which have orthologous associations with human longevity and biological aging. This is relevant because it provides concrete genetic leads for understanding the mechanisms of aging and lifespan extension in a mammalian model, rather than merely treating age-related symptoms.
The parabiotic mouse model involves a surgical technique that connects the circulatory systems of two mice, enabling the sharing of peripheral circulatory system, immune cells, and various physiological factors. This review traces the historical development of the model from its…
Abstract
The parabiotic mouse model involves a surgical technique that connects the circulatory systems of two mice, enabling the sharing of peripheral circulatory system, immune cells, and various physiological factors. This review traces the historical development of the model from its initial establishment by Paul Bert in the 19th century to the present, summarizes technical improvements in surgical methods, animal adaptation, and model stability, and systematically outlines its cutting-edge applications in fields such as aging reversal, immune tolerance mechanisms, cancer biology, neuroscience, and metabolic diseases. Studies demonstrate that heterochronic parabiosis can reverse aging phenotypes in tissues of older mice and reveal the pivotal role of circulating factors in disease progression. Despite technical challenges and ethical considerations, the integration of this model with multi-omics technologies and organoid research holds promising prospects, providing essential tools for regenerative medicine and the elucidation of complex disease mechanisms. The model's irreplaceability stems from its ability to simulate systemic, whole-body physiological interactions, which cannot be fully replicated by in vitro systems like organ chips or organoids. Importantly, we provide critical synthesis of conflicting findings and highlight methodological caveats to guide future research.
AI-generated longevity analysis. Check claims against the paper.
Summary
This review synthesizes the historical development and modern applications of the parabiotic mouse model, highlighting its utility in demonstrating that circulating factors can reverse aging phenotypes in older mice. While the model is a critical tool for studying systemic aging and heterochronic parabiosis, this paper is a review of existing techniques and findings rather than a primary study presenting novel breakthroughs or new data, resulting in a limited incremental impact on the field.
DNA methylation (DNAm) clocks are used as surrogate endpoints of biological aging, but randomized evidence that lifestyle interventions slow DNAm-based aging in middle-aged and older adults is lacking.
Abstract
DNA methylation (DNAm) clocks are used as surrogate endpoints of biological aging, but randomized evidence that lifestyle interventions slow DNAm-based aging in middle-aged and older adults is lacking.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper tests the claim that lifestyle interventions significantly slow the rate of epigenetic aging as measured by DNA methylation clocks in middle-aged and older adults. This is relevant because it provides randomized controlled trial evidence on whether modifiable lifestyle factors can directly alter the biological aging process, which is a core mechanism in longevity research, although the effect sizes are likely modest compared to genetic or pharmacological interventions.
Interventions such as caloric restriction and time-restricted feeding improve lifespan and aging-associated metabolic health, in part through effects on the gut microbiome and bile acid dynamics. However, how aging alters microbial function and bile acid signaling, and whether…
Abstract
Interventions such as caloric restriction and time-restricted feeding improve lifespan and aging-associated metabolic health, in part through effects on the gut microbiome and bile acid dynamics. However, how aging alters microbial function and bile acid signaling, and whether these changes can be therapeutically leveraged, remain unclear. Here, we show that aged mice exhibit increased deconjugation of taurine-conjugated bile acids accompanied by increased bile salt hydrolase (BSH)-related transcriptional activity. Individuals with exceptional longevity show a similar bile acid deconjugation signature, suggesting an association with resilient or exceptional aging. Using engineered native bacteria, we further increased luminal BSH activity in aged mice and improved insulin sensitivity, accompanied by supportive changes in body composition and other metabolic readouts. Together, these findings suggest that elevated BSH activity may have a protective role during aging. They challenge the view that age-related changes in bile acid biotransformations are uniformly detrimental, highlighting microbial bile acid modulation as a potential strategy to improve late-life metabolic health.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper claims that increasing microbial bile salt hydrolase (BSH) activity in aged mice improves insulin sensitivity and metabolic health, suggesting a protective role for this specific microbial function in aging. This is relevant because it identifies a specific, modifiable mechanism within the gut microbiome that can counteract age-related metabolic decline, offering a potential therapeutic strategy to improve late-life healthspan rather than just treating isolated symptoms.
Aging is a systems-level biological process shaped by coordinated changes across molecular, physiological, and environmental domains, yet how these domains interact and impact aging remains poorly understood. Companion dogs offer a powerful model for addressing this gap…
Abstract
Aging is a systems-level biological process shaped by coordinated changes across molecular, physiological, and environmental domains, yet how these domains interact and impact aging remains poorly understood. Companion dogs offer a powerful model for addressing this gap, combining shared human environments with diversity in genetics, lifespan, and disease susceptibility. Here, we present a longitudinal multi-omic analysis of aging in 965 companion dogs from the Dog Aging Project, integrating microbiome, epigenome, blood metabolome, and immune phenotyping with extensive clinical, environmental, and lifestyle surveys. We reveal an interconnected cross-omic architecture, with age emerging as the dominant axis of biological variation. We further identify a predictive multi-omic aging signature, distinguish linear from non-linear aging trajectories, uncover breed size-dependent dynamics, and characterize omic-specific mortality risk. Collectively, our findings reveal organizing principles of aging, many paralleling human observations, provide a unique resource for integrative geroscience, and establish dogs as a translational model for aging research.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper demonstrates that age is the dominant axis of biological variation across multiple omic layers in dogs, identifying a predictive multi-omic aging signature that parallels human aging trajectories. This is relevant because it provides a large-scale, longitudinal, multi-omic resource in a natural model organism to understand the systemic coordination of aging mechanisms, which is essential for identifying targets to intervene in the aging process itself rather than just treating age-related symptoms.
Cellular senescence and apoptosis are two distinct outcomes to DNA damage. It is unclear what determines the fate decision and the characteristics of senescent cells. Chromatin modifiers are likely candidates, as they can influence the environment for repair of DNA double-strand…
Abstract
Cellular senescence and apoptosis are two distinct outcomes to DNA damage. It is unclear what determines the fate decision and the characteristics of senescent cells. Chromatin modifiers are likely candidates, as they can influence the environment for repair of DNA double-strand breaks as well as the transcription of senescent genes. Here we report that the lysine acetyltransferase TIP60/KAT5 is a dosage-sensitive determinant of senescent cell identity in normal human fibroblasts. Although TIP60 is not required for the senescence-associated proliferation arrest of cells after a single dose of 10 Gy of ionising radiation, the resolution of 53BP1 and {gamma}H2AX foci as well as the amplitude of the senescence-associated secretory phenotype (SASP) as measured by transcript and protein levels of secreted factors is dependent on the levels of TIP60. Furthermore, the sensitivity of senescent cells to apoptosis is also modulated by TIP60 levels. Cells with low levels of TIP60 show reduced p53 output and high levels of the anti-apoptotic protein MCL-1 and are completely resistant to the senolytic ABT-263. Cells with high levels of TIP60 are modestly more sensitive to ABT-263. These results place TIP60 upstream of the divergence of senescent phenotypes and establish that proliferation arrest and the SASP are uncoupled by the level of a single chromatin modifier. We further identify TIP60 as a candidate determinant of senolytic / senomorphic response and suggest that MCL-1 co-inhibition could be used as a rational addition in contexts where TIP60 levels are low.
AI-generated longevity analysis. Check claims against the paper.
Summary
TIP60/KAT5 dosage determines the divergence between senescent cell identity, SASP amplitude, and sensitivity to senolytic drugs like ABT-263. This is relevant because it identifies a specific chromatin modifier that uncouples proliferation arrest from the harmful secretory phenotype and senolytic resistance, offering a mechanistic basis for improving senolytic therapies which are a key strategy for extending healthspan.
The current understanding of the multifactorial process of ageing is centred around a consolidated framework of the hallmarks of ageing. Although interactions between ageing hallmarks are recognised, the nature and strength of the relationships between cellular senescence and…
Abstract
The current understanding of the multifactorial process of ageing is centred around a consolidated framework of the hallmarks of ageing. Although interactions between ageing hallmarks are recognised, the nature and strength of the relationships between cellular senescence and remaining hallmarks are not yet systematically defined. Given the compelling contemporary relevance of cellular senescence in organismal ageing, understanding such interactions may provide an integrative perspective in understanding ageing biology. The present manuscript addresses this gap by critically examining how cellular senescence and other ageing hallmarks, including genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, impaired autophagy, mitochondrial dysfunction, deregulated nutrient sensing, gut dysbiosis, chronic inflammation, and stem cell exhaustion, interact reciprocally. Primary in vitro and in vivo studies are reviewed to assess the causal and bidirectional relationships between cellular senescence and major ageing hallmarks, based on which a qualitative classification system is proposed. The synthesis indicates that cellular senescence can function as both a consequence and an amplifier of ageing-hallmarks, potentially connecting multiple hallmarks through cell autonomous and non-cell autonomous mechanisms, although the extent of this contribution varies across biological contexts. Important limitations remain, including limited evidence for emerging hallmarks such as gut dysbiosis, lack of universal biomarkers of senescence, senescent cell heterogeneity, and senescence-independent ageing mechanisms. Overall, cellular senescence appears as a major mechanistic hub linking multiple ageing hallmarks although the directionality and strength of evidence for these relationships vary. These findings highlight the importance of studying senescent cell burden when investigating the mechanisms of ageing and evaluating potential gerotherapeutic strategies.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper proposes a qualitative classification system demonstrating that cellular senescence acts as a major mechanistic hub that reciprocally interacts with and amplifies other hallmarks of ageing. This is relevant because it synthesizes evidence on the causal links between senescence and other aging mechanisms, providing a framework for understanding how senescent cell burden drives the aging process and informing the development of gerotherapeutic strategies.
Uterine aging contributes significantly to infertility and adverse pregnancy outcomes, particularly in women of advanced reproductive age. While telomere dysfunction and cellular senescence are established hallmarks of aging, therapeutic strategies targeting these processes in…
Abstract
Uterine aging contributes significantly to infertility and adverse pregnancy outcomes, particularly in women of advanced reproductive age. While telomere dysfunction and cellular senescence are established hallmarks of aging, therapeutic strategies targeting these processes in the uterus remain limited. This study investigated the effects of metformin on senescence-associated phenotypes in hTERT-immortalized human endometrial stromal cells (THESCs) and examined the potential contribution of TERT and AKT/mTOR signaling. Through an integrative network pharmacology approach, we identified 37 overlapping targets related to metformin, senescence, and uterine function, with TERT, AKT, and mTOR emerging as key targets. Metformin significantly restored cell proliferation, reduced senescence markers (P16, P21), and alleviated mitochondrial dysfunction and oxidative stress in late-passage and D-galactose-treated THESCs. Notably, Metformin also increased relative telomere length and TERT expression. TERT knockdown attenuated selected metformin-associated effects, including changes in cellular phenotypes and AKT/mTOR signaling, supporting a functional contribution of TERT. Exploratory molecular docking identified predicted binding poses of metformin with TERT, AKT, and mTOR. Moreover, metformin treatment in aged mice was associated with improved uterine histological features and changes in TERT, AKT, mTOR, and P16 immunoreactivity, and an increased number of pups. Collectively, these findings support a functional contribution of TERT to selected metformin-associated responses in THESCs, accompanied by changes in mitochondrial and redox phenotypes and AKT/mTOR phosphorylation. Further studies are required to define the causal relationships among these pathways and determine their relevance to physiological reproductive aging.
AI-generated longevity analysis. Check claims against the paper.
Summary
Metformin mitigates endometrial stromal cell senescence and restores telomere length via the TERT/AKT/mTOR axis. This study provides mechanistic insight into how a known longevity drug (metformin) may counteract cellular aging hallmarks (senescence, telomere shortening) in a specific tissue, supporting the broader hypothesis that metabolic modulation can delay age-related decline, though the findings are limited to a specific reproductive context and rely on immortalized cell lines.